Ethics declarations Ethics approval and consent to participate The Ethics Committee at Karolinska Institutet, Stockholm, approved the study and clinical register (No
The Medicines and Healthcare products Regulatory Agency (MHRA) and manufacturers' Summaries of Product Characteristics (SmPCs) consistently advise against using GLP-1 receptor agonists whilst breastfeeding due to insufficient data on excretion into human breast milk and potential effects on nursing infants
Natural Energy & Immune Strength: With 100mg quercetin and 50mg green tea extractstandardized to 95% polyphenols and 45% EGCGthis sulforaphane blend strengthens immunity, supports healthy inflmmation response, and naturally boosts daily energy
Supplementary Materials Data Availability Statement The data presented in this study are available on request from the corresponding author.
This approach also supports weight loss by increasing daily calorie expenditure, making it a dual-benefit strategy
Published online May 1, 2025 DOI: 14,446 View 512 Download 28 Web of Science 31 Crossref Abstract PDFPubReader ePub Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as blockbuster drugs for treating metabolic diseases